Sign Up Today and Learn More About Medrobotics Stock

Invest in or calculate the value of your shares in Medrobotics or other pre-IPO companies through EquityZen's platform.

Get Started

Medrobotics Stock

Medrobotics Corporation is a medical robotics company developing and commercializing the Flex Robotic System.

About Medrobotics Stock

Founded

2005

Headquarters

Raynham, MA, US

Total Funding

164M

Medrobotics Corporation (formerly Cardioborobotics, Inc.) is a Delaware "C" Corporation, originally formed in 2005 (as Innovention Technologies, LLC) by the inventors of our technology. They are Howie Choset, PhD, a tenured Associate Professor of Robotics at Carnegie Mellon University, Dr. Marco Zenati, a cardiothoracic surgeon and Visiting Professor of Surgery at Harvard Medical School, and Dr. Alon Wolf, Associate Professor at Technion University in Israel. Dr. Zenati was on the medical faculty of the University of Pittsburgh at the time he and Drs. Choset and Wolf developed the first generation medical "snake robotics" platform in-licensed by the Company. Dr. Choset and Dr. Zenati continue to remain involved in technology development at the Company. Medrobotics has exclusive worldwide licenses for its technologies from Carnegie Mellon University and the University of Pittsburgh as well as additional robust development of its own intellectual property portfolio. The Company has an operational facility in New England, with partners located throughout the United States.

Medrobotics Press Mentions

Stay in the know about the latest news on Medrobotics

Medrobotics Management

Leadership team at Medrobotics

Vice President, Global Sales

Richard Walsh

Chief Financial Officer & Treasurer

Mark Peters

Locked Features

Join now and verify your accreditation status to gain access to:

  • Medrobotics current valuation
  • Medrobotics stock price
  • Available deals in Medrobotics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Medrobotics stock?

Accredited investors can buy pre-IPO stock in companies like Medrobotics through EquityZen funds. These investments are made available by existing Medrobotics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Medrobotics stock?

Shareholders can sell their Medrobotics stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."